The National Health Service is set to revolutionize the detection of womb cancer with an artificial intelligence-powered blood test. The initiative aims to identify women referred for possible womb cancer before undergoing invasive checks, which are typically carried out under strict medical supervision. According to reports from The Guardian, around 90,000 postmenopausal women in England are diagnosed each year after experiencing heavy bleeding.
The NHS AI blood test is expected to significantly reduce the number of unnecessary invasive womb cancer checks. Currently, a typical routine check involves a combination of ultrasound and biopsies, which can be complex and pose risks to patients. The new technology uses machine learning algorithms to analyze blood samples from women suspected of having womb cancer, allowing for more accurate diagnoses.
Experts are hailing the NHS AI blood test as a significant step forward in cancer detection. By improving diagnostic accuracy and reducing the need for invasive checks, this initiative could ultimately lead to better patient outcomes and increased life expectancy. The rollout is expected to begin soon, with multiple NHS hospitals set to implement the new system.